AVN 65.31 Decreased By ▼ -0.86 (-1.3%)
BAFL 30.25 No Change ▼ 0.00 (0%)
BOP 4.63 Decreased By ▼ -0.10 (-2.11%)
CNERGY 3.89 Decreased By ▼ -0.12 (-2.99%)
DFML 13.50 Decreased By ▼ -0.60 (-4.26%)
DGKC 42.15 Decreased By ▼ -1.54 (-3.52%)
EPCL 46.13 Increased By ▲ 1.48 (3.31%)
FCCL 11.45 Decreased By ▼ -0.38 (-3.21%)
FFL 5.19 Increased By ▲ 0.22 (4.43%)
FLYNG 5.82 Decreased By ▼ -0.28 (-4.59%)
GGL 10.04 Decreased By ▼ -0.34 (-3.28%)
HUBC 63.21 Increased By ▲ 0.91 (1.46%)
HUMNL 5.73 Decreased By ▼ -0.12 (-2.05%)
KAPCO 27.81 Increased By ▲ 0.26 (0.94%)
KEL 2.15 Decreased By ▼ -0.06 (-2.71%)
LOTCHEM 25.37 Decreased By ▼ -1.23 (-4.62%)
MLCF 21.65 Decreased By ▼ -0.87 (-3.86%)
NETSOL 84.95 Decreased By ▼ -1.25 (-1.45%)
OGDC 86.64 Increased By ▲ 0.37 (0.43%)
PAEL 10.96 Decreased By ▼ -0.31 (-2.75%)
PIBTL 4.21 Decreased By ▼ -0.07 (-1.64%)
PPL 78.65 Decreased By ▼ -1.43 (-1.79%)
PRL 13.61 Decreased By ▼ -0.05 (-0.37%)
SILK 0.88 Decreased By ▼ -0.02 (-2.22%)
SNGP 41.00 Decreased By ▼ -0.75 (-1.8%)
TELE 6.01 Decreased By ▼ -0.20 (-3.22%)
TPLP 16.02 Decreased By ▼ -0.25 (-1.54%)
TRG 111.89 Decreased By ▼ -0.66 (-0.59%)
UNITY 14.01 Decreased By ▼ -0.34 (-2.37%)
WTL 1.14 Decreased By ▼ -0.06 (-5%)
BR100 4,026 Decreased By -48.6 (-1.19%)
BR30 14,402 Decreased By -123 (-0.85%)
KSE100 40,451 Decreased By -396 (-0.97%)
KSE30 15,110 Decreased By -101.7 (-0.67%)
Follow us

GENEVA: The World Health Organization on Thursday authorised the use of Chinese manufacturer CanSinoBIO’s single-shot Covid-19 vaccine — the ninth jab to get the WHO green light.

The WHO granted emergency use listing (EUL) to the Tianjin-based firm’s Convidecia vaccine as China battles a resurgence of the virus triggered by the Omicron variant.

It is the third Chinese-made vaccine to be approved by the WHO, after Sinovac and Sinopharm.

Convidecia was found to have 64 percent efficacy against symptomatic disease and 92 percent efficacy against severe Covid-19, the WHO said.

“The vaccine meets WHO standards for protection against Covid-19 and ... the benefits of the vaccine far outweigh risks,” the UN health agency said in a statement.

The WHO’s vaccine experts recommended it for people aged 18 and above.

The jab has already been rolled out in China, Argentina, Chile, Malaysia, Mexico and Pakistan.

The WHO has now given EUL status to nine Covid-19 vaccines and variations thereof — Pfizer/BioNTech, AstraZeneca, Janssen, Moderna, Sinovac, Sinopharm, Bharat Biotech, Novavax and now CanSinoBIO.

The UN health agency began reviewing rolling data on the CanSinoBIO vaccine in August. The WHO says EUL approval gives countries, funders, procuring agencies and communities assurance that the vaccine has met international standards.

WHO’s listing paves the way for countries to approve and import a vaccine for distribution quickly, especially those without an international-standard regulator of their own.

It also opens the door for the jabs to enter the Covax global vaccine-sharing facility, which aims to provide equitable access to doses around the world, particularly in poorer countries.

Comments

Comments are closed.

WHO authorises China’s CanSinoBIO Covid-19 vaccine

Suddenly, ailing SOEs come under PDM govt’s focus

At least 39 killed as passenger coach falls into ravine in Lasbela

LPG hits historic high of Rs300/kg: LPGA demands setting up of probe commission

50pc duty imposed on import of ‘Mild Hybrid Vehicles’

Pakistan expresses interest in possibility of currency swap with Russia

Al-Nahyan due tomorrow to discuss trade, investment

Flood-hit areas: Rs8.39bn subsidy to be provided to farmers

FBR readies presentation for IMF

Ogra rejects oil price speculations

Live debate on economy: Tarin accepts challenge